QXO Launches Hostile Takeover Bid for Beacon Building Products After Repeated Rejections Sindhu Trade Links Shares Surge After Approving Acquisitions and Capital Hike Elon Musk Clarifies SpaceX Not Committed to LongTerm Colossus Lease with Anthropic India Captures Data Center Growth Despite Limited Direct AI Chip Sector Exposure Forbes Sports Money Offers Viewing Guide for 110th Indianapolis 500 Highlighting Events Media Stature US and Iran Show Signs of Progress in Talks but Disagreements Over Enriched Uranium and Strait of Hormuz Tolls Persist Cavco Industries Q1 2026 Earnings EPS Beats Estimates by 102 Stock Rises 36 MLI Q1 2026 Earnings Strong Earnings Beat as EPS Surges Past Estimates Hinge Health HNGE Q1 2026 Earnings EPS Beats by 163 Stock Moves Higher AVGO Q1 2026 Earnings Narrow EPS Miss Amid Modest Market Response CAMT Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises RenaissanceRe Holdings Ltd RNR Q1 2026 Earnings Strong Underwriting Results Drive EPS Beat Aspire Biopharma Holdings Warrants ASBPW Languish at Penny Level as Support and Resistance Converge Magyar Bancorp MGYR Edges Lower Amid Modest Pullback Key Support Levels Hold Cytosorbents Corporation CTSO Edges Higher Amid LowVolume Trading ASGN Incorporated ASGN Plunges 5169 Key Levels and What Lies Ahead Waystar Holding Corp WAY Edges Higher Amid Modest Gains Waymos Expanded Autonomous Fleet Hits the Road Spacious Ojai Robotaxi Faces Early Glitches Novartis Q1 2026 Earnings EPS Falls Short of Estimates by 852 Stock Edges Higher Entegris Inc ENTG Shows Modest Decline Amidst Tight Trading Range Instil Bio Inc TIL Q1 2026 Earnings WiderThanExpected Loss as Biotech Continues PreCommercial Phase PTCT Q1 2026 Earnings Significant EPS Beat Highlights Cost Discipline Amid Pipeline Progress Omnicell Inc OMCL Q1 2026 Earnings EPS Surges Past Estimates Stock Slips GATX Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Railcar Leasing Demand GCBC Q2 2025 Earnings Solid EPS Performance Amid Steady Banking Operations ABUS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline PAPL Q3 2025 Earnings EPS Surprises Significantly Above Estimates Despite Stock Decline